Evidence base for investigative and therapeutic modalities in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy

Hendrik Stephan Goedee, Yusuf A Rajabally*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Chronic inflammatory demyelinating polyneuropathy, its variants and multifocal motor neuropathy belong to a spectrum of peripheral nerve disorders with complex dysimmune disease mechanisms. Awareness of the unique clinical phenotypes but also heterogeneity between patients is vital to arrive at early suspicion and ordering appropriate tests. This includes requirements for optimal electrodiagnostic protocol, aimed to capture sufficient electrophysiologic evidence for relevant abnormalities, a case-based approach on the eventual need to further expand the diagnostic armamentarium and correct reading of their results. Considerable phenotypical variation, diverse combinations of abnormalities found on diagnostic tests and heterogeneity in disease course and treatment response, all contribute to widespread differences in success rates on timely diagnosis and optimal treatment. We aim to provide a practical overview and guidance on relevant diagnostic and management strategies, including pitfalls and present a summary of the relevant novel developments in this field.
Original languageEnglish
Pages (from-to)35-47
Number of pages13
JournalNeurodegenerative disease management
Volume12
Issue number1
Early online date10 Jan 2022
DOIs
Publication statusPublished - Feb 2022

Keywords

  • CIDP
  • MMN
  • diagnostic
  • inflammatory neuropathy
  • treatment

Fingerprint

Dive into the research topics of 'Evidence base for investigative and therapeutic modalities in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy'. Together they form a unique fingerprint.

Cite this